Acute vaccine-induced-pericarditis after COVID-induced myocarditis
49-year-old woman was diagnosed with myocarditis and pulmonary embolism due to a COVID-19 complication, which led to heart failure with reduced ejection fraction. A month later she received the first dose of the Pfizer–BioNTech COVID-19 vaccine with no notable side effects. 12 days after her second dose, however, sheA computed tomography (CT) angiography (showed pleural effusion, larger in the right hemithorax. Based on the patient’s medical record, this clinical presentation was interpreted as acute decompensated heart failure stage C (“cold and wet") and later with perimyocarditis.
The patient was stabilized with dobutamine infusion and treated with naproxen 500mg twice a day and colchicine 0.5 mg twice a day and showed significant clinical improvement.
Voltarelli CL, Silva L, Longo M, Ferraria S, Martins LL, Nazar G, Magalhães T, Miyazima R, Lenci Marques G. COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report. Cureus. 2022 Aug 26;14(8):e28440. doi: 10.7759/cureus.28440. PMID: 36176830; PMCID: PMC9509695.